ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Four More O.I. Awards Announced; Pediatric Clinical Trials RFP Canceled

September 6, 1985

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

Wynder, Weinburg Head Recipients Of Milken Awards

December 14, 1990

Levine, Mendelsohn Win Landon Awards; Ullrich Wins Pezcoller.

February 29, 2008

South Carolina Clinic and Anil Potti Part Ways

February 24, 2012